Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)
Clinical trial NCT02522975 · TERMINATED
Trial details
- NCT number
- NCT02522975
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2019-06-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.